The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/18725374

Download in:

View as

General Info

PMID
18725374